Effects of acute stress on cardiac endocannabinoids, lipogenesis, and inflammation in rats

Psychosomatic Medicine

Volumn 76, Issue 1, 2014, Pages 20-28

  Holman, Ellen Alison ^a   Guijarro, Ana ^b,c   Lim, James ^b   Piomelli, Daniele ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

acute stress; cardiovascular status; endocannabinoids; inflammation; lipogenesis; triacylglycerols.

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYL COENZYME A DESATURASE; BRAIN NATRIURETIC PEPTIDE; ENDOCANNABINOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; N OLEOYLETHANOLAMINE; PALMIDROL; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CARDIOVASCULAR RISK; CARDITIS; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; ELEVATED PLUS MAZE TEST; ENZYME ACTIVITY; HEART FAILURE; HEART STRESS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPID METABOLISM; LIPOGENESIS; MALE; NONHUMAN; ODOR; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE STRESS; CARDIOVASCULAR STATUS; ENDOCANNABINOIDS; INFLAMMATION; LIPOGENESIS; TRIACYLGLYCEROLS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; ENDOCANNABINOIDS; HEART DISEASES; INFLAMMATION; LIPOGENESIS; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STRESS DISORDERS, TRAUMATIC, ACUTE; TIME FACTORS;

EID: 84892988491     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000025     Document Type: Article

References (42)

1. Wittstein IS. Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning? Cell Mol Neurobiol 2012;32:847-57.
2. Boscarino JA. A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom Med 2008;70:668-76.
3. Holman EA, Silver RC, Poulin M, Andersen J, Gil-Rivas V, McIntosh DN. Terrorism, acute stress, and cardiovascular health: a 3-year national study following the September 11th attacks. Arch Gen Psychiatry 2008;65: 73-80.
4. Holbrook TL, Galarneau MR, Dye JL, Quinn K, Dougherty AL. Morphine use after combat injury in Iraq and post-traumatic stress disorder. New Engl J Med 2010;362:110-7.
5. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statisticsV2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480-6.
6. Steptoe A, Kivimaki M. Stress and cardiovascular disease. Nat Rev Cardiol 2012;9:360-70.
7. Chida Y, Steptoe A. Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension 2010;55:1026-32.
8. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D. Modulation of anxiety through blockade of anan-damide hydrolysis. Nature medicine 2003;9:76-81.
9. Dipatrizio NV, Piomelli D. The thrifty lipids: endocannabinoids and the neural control of energy conservation. Trends Neurosci 2012;35:403-11.
10. Hill MN, Tasker JG. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 2012;204:5-16.
11. O'Sullivan SE, Kendall PJ, Kendall DA. Endocannabinoids and the cardiovascular response to stress. J Psychopharmacol 2012;26:71-82.
12. Montecucco F, Di Marzo V. At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction. Trends Pharmacol Sci 2012;33:331-40.
13. Berdyshev E, Boichot E, Corbel M, Germain N, Lagente V. Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci 1998;63:PL125-9.
14. Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve AJ, Chapman V. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2008;10:R43.
15. Su HF, Samsamshariat A, Fu J, Shan YX, Chen YH, Piomelli D, Wang PH. Oleylethanolamide activates RAS-ERK pathway and improves myocardial function in doxorubicin-induced heart failure. Endocrinology 2006;147: 827-34.
16. Cohen H, Kozlovsky N, Alona C, Matar MA, Joseph Z. Animal model for PTSD: from clinical concept to translational research. Neuropharmacology 2012;62:715-24.
17. Hotsenpiller G, Williams JL. A synthetic predator odor (TMT) enhances conditioned analgesia and fear when paired with a benzodiazepine receptor inverse agonist (FG-7142). Psychobiology 1997;25:83-8.
18. Hebb AL, Zacharko RM, Gauthier M, Drolet G. Exposure of mice to a predator odor increases acoustic startle but does not disrupt the rewarding properties of VTA intracranial self-stimulation. Brain Res 2003;982: 195-210.
19. Palazzuoli A, Caputo M, Calabro A, Nuti R. Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management. Min Cardioangiol 2012;60:183-94.
20. Vassiliadis E, Barascuk N, Didangelos A, Karsdal MA. Novel cardiac-specific biomarkers and the cardiovascular continuum. Biomarker Insights 2012;7:45-57.
21. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferatorYactivated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 2005;67:15-9.
22. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999;6:99-104.
23. Pryor WA. The antioxidant nutrients and disease preventionVwhat do we know and what do we need to find out? Am J Clin Nutr 1991;53:391SY3S.
24. Chen AF, Chen DD, Daiber A, Faraci FM, Li H, Rembold CM, Laher I. Free radical biology of the cardiovascular system. Clin Sci (Lond) 2012; 123:73-91.
25. de Cavanagh EMV, Inserra F, Ferder L. Angiotensin ii blockade: a strategy to slow ageing by protecting mitochondria? Cardiovasc Res 2011;89: 31-40.
26. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2010;2:247-57.
27. Yang C, Wang Y, Liu H, Li N, Sun Y, Liu Z, Yang P. Ghrelin protects H9C2 cardiomyocytes from angiotensin IIYinduced apoptosis through the endo-plasmic reticulum stress pathway. J Cardiovasc Pharmacol 2012;59:465-71.
28. Stoney CM, Bausserman L, Niaura R, Marcus B, Flynn M. Lipid reactivity to stress: II. Biological and behavioral influences. Health Psychol 1999;18:251-61.
29. Stoney CM, West SG, Hughes JW, Lentino LM, Finney ML, Falko J, Bausserman L. Acute psychological stress reduces plasma triglyceride clearance. Psychophysiology 2002;39:80-5.
30. Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep 2011;13:544-52.
31. Ruby MA, Nomura DK, Hudak CS, Mangravite LM, Chiu S, Casida JE, Krauss RM. Overactive endocannabinoid signaling impairs apolipoprotein e-mediated clearance of triglyceride-rich lipoproteins. Proc Nat Acad Sci 2008;105:14561-6.
32. Rajesh M, Batkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horvath B, Holovac E, Cinar R, Liaudet L, Mackie K, Hasko G, Pacher P. Cannabinoid I receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 2012;61:716-27.
33. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011;60:1500-10.
34. Hongo M, Ishizaka N, Furuta K, Yahagi N, Saito K, Sakurai R, Matsuzaki G, Koike K, Nagai R. Administration of angiotensin II, but not catechol-amines, induces accumulation of lipids in the rat heart. Eur J Pharmacol 2009;604:87-92.
35. Saavedra JM, Sanchez-Lemus E, Benicky J. Blockade of brain angiotensin II at1 receptors ameliorates stress, anxiety, brain inflammation and ische mia: therapeutic implications. Psychoneuroendocrinology 2011;36:1-18.
36. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F, Duranti A, Tontini A, Cuzzocrea S, Tarzia G, Piomelli D. Selective N-acylethanolamineYhydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Nat Acad Sci 2009;106:20966-71.
37. Lingvay I, Raskin P, Szczepaniak LS. The fatty hearts of patients with diabetes. Nat Rev Cardiol 2009;6:268-9.
38. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004; 18:1692-1700.
39. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. Br Med J 2012;345:e4933.
40. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000;68:748-66.
41. Adamec R, Holmes A, Blundell J. Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factorsVrelevance to PTSD. Neurosci Biobehav Rev 2008;32:1287.
42. Quinn R. Comparing rat's to human's age: how old is my rat in people years? Nutrition 2005;21:775-7.